New research shows propranolol, a commonly used blood pressure and migraine medication, may cut ischemic stroke risk by up to 52% in women with migraines—particularly those without aura—while showing no protective effect in men.
SYMBRAVO (meloxicam and rizatriptan) has received U.S. Food and Drug Administration approval for the acute treatment of migraine with or without aura in adults.
"These findings highlight the need to identify biological mechanisms contributing to sex specificity to facilitate risk stratification, targeted drug development, and improved management of long COVID," wrote the study's authors.
Explore the latest transcranial magnetic stimulation guidelines for depression, including updated protocols, safety data, and tailored recommendations for clinicians.
A 2024 study of 85 pregnancies found no shunt malfunctions during pregnancy and only a 5.9% postpartum revision rate, contradicting decades of data on shunt failure risks for pregnant women.